BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8106619)

  • 21. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy.
    Syed MA; Horwitz MJ; Tedesco MB; Garcia-Ocaña A; Wisniewski SR; Stewart AF
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1525-31. PubMed ID: 11297578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism.
    Firek AF; Kao PC; Heath H
    J Clin Endocrinol Metab; 1991 Mar; 72(3):541-6. PubMed ID: 1997510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary excretion of parathyroid hormone-related protein fragments in patients with humoral hypercalcemia of malignancy and hypercalcemic tumor-bearing nude mice.
    Imamura H; Sato K; Shizume K; Satoh T; Kasono K; Ozawa M; Ohmura E; Tsushima T; Demura H
    J Bone Miner Res; 1991 Jan; 6(1):77-84. PubMed ID: 2048434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humans.
    Everhart-Caye M; Inzucchi SE; Guinness-Henry J; Mitnick MA; Stewart AF
    J Clin Endocrinol Metab; 1996 Jan; 81(1):199-208. PubMed ID: 8550752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay.
    Blind E; Schmidt-Gayk H; Scharla S; Flentje D; Fischer S; Göhring U; Hitzler W
    J Clin Endocrinol Metab; 1988 Aug; 67(2):353-60. PubMed ID: 3292561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A midregion parathyroid hormone-related peptide mobilizes cytosolic calcium and stimulates formation of inositol trisphosphate in a squamous carcinoma cell line.
    Orloff JJ; Ganz MB; Nathanson MH; Moyer MS; Kats Y; Mitnick M; Behal A; Gasalla-Herraiz J; Isales CM
    Endocrinology; 1996 Dec; 137(12):5376-85. PubMed ID: 8940360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levels of parathyroid hormone-related protein in hypercalcemia of malignancy: comparison of midregional radioimmunoassay and two-site immunoradiometric assay.
    Blind E; Raue F; Meinel T; Bucher M; Manegold C; Ebert W; Vogt-Moykopf I; Ziegler R
    Clin Investig; 1993 Jan; 71(1):31-6. PubMed ID: 8453257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia].
    Blind E; Raue F; Meinel T; Pecherstorfer M; Räth U; Schmidt-Gayk H; Kohl B; Ziegler R
    Dtsch Med Wochenschr; 1993 Mar; 118(10):330-5. PubMed ID: 8453901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumors of the parathyroid gland and circulating parathyroid hormone-related protein associated with persistent hypercalcemia.
    Rosol TJ; Capen CC
    Toxicol Pathol; 1989; 17(2):346-56. PubMed ID: 2675285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating parathyroid hormone-related protein (109-141) in malignancy-associated hypercalcemia.
    Nagasaki K; Otsubo K; Kajimura N; Tanaka R; Watanabe H; Tachimori Y; Kato H; Yamaguchi H; Saito D; Watanabe T; Adachi I; Yamaguchi K
    Jpn J Clin Oncol; 1996 Feb; 26(1):6-11. PubMed ID: 8551669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of biologically active intact parathyroid hormone in normal and hyperparathyroid sera by sequential N-terminal immunoextraction and midregion radioimmunoassay.
    Lindall AW; Elting J; Ells J; Roos BA
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1007-14. PubMed ID: 6311857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
    Horwitz MJ; Tedesco MB; Sereika SM; Syed MA; Garcia-Ocaña A; Bisello A; Hollis BW; Rosen CJ; Wysolmerski JJ; Dann P; Gundberg C; Stewart AF
    J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parathyroid hormone-related protein: evidence for isoform- and tissue-specific posttranslational processing.
    Yang KH; dePapp AE; Soifer NE; Dreyer BE; Wu TL; Porter SE; Bellantoni M; Burtis WJ; Insogna KL; Broadus AE
    Biochemistry; 1994 Jun; 33(23):7460-9. PubMed ID: 8003511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating forms of immunoreactive parathyroid hormone-related protein for identifying patients with humoral hypercalcemia of malignancy: a comparative study with C-terminal(109-141)- and N-terminal(1-86)-region-specific PTHrP radioassay.
    Suehiro M; Murakami M; Fukuchi M
    Ann Nucl Med; 1994 Nov; 8(4):231-7. PubMed ID: 7702967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
    Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parathyroid hormone-related protein-(1-36) is biologically active when administered subcutaneously to humans.
    Henry JG; Mitnick M; Dann PR; Stewart AF
    J Clin Endocrinol Metab; 1997 Mar; 82(3):900-6. PubMed ID: 9062504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parathyroid hormone-related protein in patients with primary breast cancer and eucalcemia.
    Bucht E; Rong H; Pernow Y; Nordqvist AC; Eriksson E; Rankin W; von Schoultz E; Burtis WJ; Granberg B; Falkmer UG; Burton DW; Deftos LJ
    Cancer Res; 1998 Sep; 58(18):4113-6. PubMed ID: 9751621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synovial fluids from patients with osteoarthritis and rheumatoid arthritis contain high levels of parathyroid hormone-related peptide.
    Kohno H; Shigeno C; Kasai R; Akiyama H; Iida H; Tsuboyama T; Sato K; Konishi J; Nakamura T
    J Bone Miner Res; 1997 May; 12(5):847-54. PubMed ID: 9144352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia/lymphoma and B-cell lymphoma.
    Ikeda K; Ohno H; Hane M; Yokoi H; Okada M; Honma T; Yamada A; Tatsumi Y; Tanaka T; Saitoh T
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1322-7. PubMed ID: 7962324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical localization of parathyroid hormone-related protein in parathyroid adenoma and hyperplasia.
    Danks JA; Ebeling PR; Hayman JA; Diefenbach-Jagger H; Collier FM; Grill V; Southby J; Moseley JM; Chou ST; Martin TJ
    J Pathol; 1990 May; 161(1):27-33. PubMed ID: 2196348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.